Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
SpainA study of PM54 and pembrolizumab in adults with advanced cancer
SpainStudy of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin
SpainA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
SpainA study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
SpainA study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis
SpainA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
SpainA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
SpainA study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations
SpainA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
SpainA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
SpainA study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
